CBX5 and myeloid sarcoma: Thus, reduced CBX5 activity in patients with MS offers a potential rationale for the concurrent elevation in the activity of proinflammatory cytokine genes and normally heterochromatinized DNA repeats, such as endogenous retroviruses (HERVs).